Page last updated: 2024-10-21

8-hydroxy-2-(di-n-propylamino)tetralin and Smoking Cessation

8-hydroxy-2-(di-n-propylamino)tetralin has been researched along with Smoking Cessation in 1 studies

8-Hydroxy-2-(di-n-propylamino)tetralin: A serotonin 1A-receptor agonist that is used experimentally to test the effects of serotonin.
8-OH-DPAT : A tetralin substituted at positions 1 and 7 by hydroxy and dipropylamino groups respectively

Smoking Cessation: Discontinuing the habit of SMOKING.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rasmussen, K1
Calligaro, DO1
Czachura, JF1
Dreshfield-Ahmad, LJ1
Evans, DC1
Hemrick-Luecke, SK1
Kallman, MJ1
Kendrick, WT1
Leander, JD1
Nelson, DL1
Overshiner, CD1
Wainscott, DB1
Wolff, MC1
Wong, DT1
Branchek, TA1
Zgombick, JM1
Xu, YC1

Other Studies

1 other study available for 8-hydroxy-2-(di-n-propylamino)tetralin and Smoking Cessation

ArticleYear
The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:2

    Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Acoustic Stimulation; Animals; Body Temperature; Columbidae;

2000